These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 572254)

  • 1. Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings].
    Jenner P; Marsden CD; Reavill C
    Br J Pharmacol; 1979 May; 66(1):103P-104P. PubMed ID: 572254
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
    Heal DJ; Green AR; Buylaert WA
    Neuropharmacology; 1980 Jan; 19(1):133-7. PubMed ID: 6102352
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential rotational behaviour after unilateral 5,7-dihydroxytryptamine induced lesions of the dorsal raphé nucleus [proceedings].
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Br J Pharmacol; 1979 Nov; 67(3):431P-432P. PubMed ID: 574043
    [No Abstract]   [Full Text] [Related]  

  • 5. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of morphine on turning behaviour in rats and mice with unilateral 6-hydroxydopamine lesions [proceedings].
    Blundell C; Crossman AR; Slater P
    Br J Pharmacol; 1976 Jul; 57(3):456P. PubMed ID: 987818
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotyped responses of rats to two 2-halogenoergolines: 2-bromo-alpha-ergocryptine and lergotrile.
    Bergmann F
    Isr J Med Sci; 1982 Jan; 18(1):177-82. PubMed ID: 6121772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
    Loew DM; Jaton AL; Vigouret JM
    Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
    [No Abstract]   [Full Text] [Related]  

  • 9. Sedation, stereotypy and the inhibition of drinking after administration of ET 495 in the rat [proceedings].
    Cooper SJ; Dourish CT
    Br J Pharmacol; 1979 Jul; 66(3):481P. PubMed ID: 575064
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoamine oxidase inhibitors on phencylidine induced stereotyped behavior and brain levels in rats.
    Murray TF; Horita A
    Proc West Pharmacol Soc; 1979; 22():145-7. PubMed ID: 574645
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
    Petkova B; Georgiev V; Kambourova T
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):84-90. PubMed ID: 1819920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
    Clemens JA; Okimura T; Smalstig EB
    Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotyped behavior and late chronic dyskinesias: role of anticholinergic drugs].
    Casacchia M; Cerbo R; Carchedia F; Meco G; Carolei A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):251-4. PubMed ID: 986146
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior colliculus lesions do not alter dopamine mediated circling behaviour [proceedings].
    Jenner P; Leigh N; Marsden CD; Reavill C
    Br J Pharmacol; 1979 Jul; 66(3):479P-480P. PubMed ID: 575063
    [No Abstract]   [Full Text] [Related]  

  • 18. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new bioclinical approach in psychiatry. Stereotyped behavior, psychic and behavioral disorganization, and amphetamines].
    Marchais P; Randrup A
    Ann Med Psychol (Paris); 1983; 141(7):758-70. PubMed ID: 6651116
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effect of probenecid on circling behavior of rats with unilateral quinollinic acid induced striatal lesions.
    Kravzov J; Santamaria A; Rios C; Flores A; Altagracia M
    Proc West Pharmacol Soc; 1993; 36():255-7. PubMed ID: 8378385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.